Acquiring Company
SAI Parenterals Limited
Acquired Company
Noumed
Hyderabad
AustraliaManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyPharmaceuticalDescription
SAI Parenterals Limited has acquired a 74.6% stake in Noumed, an Australian pharmaceutical firm, for AUD 22 million. This acquisition enhances SAI’s manufacturing capabilities and increases access to intellectual property dossiers. The acquisition was finalized after accelerated due diligence was completed. This strategic move supports SAI's ambition to expand in regulated pharmaceutical markets.
Quick answer
SAI Parenterals Limited is acquiring Noumed, announced December 5, 2025. SAI Parenterals Limited is based in Hyderabad, Telangana, India.
- How much did SAI Parenterals Limited pay for Noumed?
- The deal value was not disclosed.
- What does SAI Parenterals Limited do?
- SAI Parenterals Limited is a mid-sized pharmaceutical manufacturer specializing in injectable and oral dosage forms.
- Where are SAI Parenterals Limited and Noumed based?
- SAI Parenterals Limited is based in Hyderabad, Telangana, India. Noumed is based in Australia.
- Who are the decision-makers at SAI Parenterals Limited?
- Fundz holds 2 contacts at SAI Parenterals Limited. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Revolution Medicines soon (January 9, 2026)
- Cleanova acquires Airflotek and TES-Clean Air Systems (January 8, 2026)
- Sanofi acquires Dynavax Technologies for $15.50/share (December 24, 2025)
- IBA acquires ORA to strengthen nuclear medicine (December 19, 2025)
- LTS Lohmann acquires Renaissance Lakewood (December 15, 2025)
- Indutrade AB acquires ATM Group in Spain (November 18, 2025)
Who to call at SAI Parenterals Limited, and when
When SAI Parenterals Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day SAI Parenterals Limited raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SAI Parenterals Limited, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SAI Parenterals Limited. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SAI Parenterals Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Noumed?
Noumed was acquired by SAI Parenterals Limited, based in Hyderabad. The deal was reported on December 5, 2025. SAI Parenterals Limited is a mid-sized pharmaceutical manufacturer specializing in injectable and oral dosage forms. Founded in 2005, the company has been expanding its capabilities and market reach. SAI Parenterals Limited is privately held and operates in Manufacturing.
When did SAI Parenterals Limited acquire Noumed?
SAI Parenterals Limited's acquisition of Noumed was reported on December 5, 2025. SAI Parenterals Limited has acquired a 74.6% stake in Noumed, an Australian pharmaceutical firm, for AUD 22 million. This acquisition enhances SAI’s manufacturing capabilities and increases access to intellectual property dossiers. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Noumed do?
Noumed is an Australian pharmaceutical company that specializes in the development and supply of pharmaceutical products. Established in 2020, the company has filed over 450 intellectual property dossiers. It is privately held, operating in Manufacturing, and is based in Australia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.